Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

S&P reaffirms Sirtex after new offer from Chinese manager

ASX-listed healthcare firm Sirtex, whose investors include some of Australia's leading fund managers, will remain in the S&P/ASX 200 after its US takeover has been postponed in light of a new offer.

Upgrade your subscription to access this article

And gain access to:
  • All archived news content
  • Access to the Financial Standard app
  • Home page news customisation
  • Financial Standard 's fortnightly newspaper
  • 25% discount on tickets to networking events
And more
Already A Subscriber?

Read more: SirtexUSASXS&PAustraliaCDH InvestmentsUS-based Varian Medical SystemsBNP ParibasCarpe Diem Asset ManagementFederal CourtForeign Investment Review BoardHSBCIDP EducationJ.P. MorganWilliam Roberts LawyersYarra Capital